Lipocine
LPCN
LPCN
47 hedge funds and large institutions have $119M invested in Lipocine in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 45 → 47 (+2)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
Holders
47
Holding in Top 10
3
Calls
$752K
Puts
$66K
Top Buyers
| 1 | +$2.97M | |
| 2 | +$1.48M | |
| 3 | +$756K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$699K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$624K |
Top Sellers
| 1 | -$5.43M | |
| 2 | -$2.56M | |
| 3 | -$2.04M | |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$1.23M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.1M |